Insider Transactions in Q1 2021 at Illumina, Inc. (ILMN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
314
-4.39%
|
$130,624
$416.24 P/Share
|
|
Mar 16
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.37%
|
$1,684,000
$421.06 P/Share
|
|
Mar 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
800
-1.75%
|
$321,600
$402.24 P/Share
|
|
Mar 02
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.31%
|
$1,776,000
$444.61 P/Share
|
|
Feb 18
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
666
-30.22%
|
$323,676
$486.75 P/Share
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,635
-18.62%
|
$807,690
$494.24 P/Share
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,503
+28.52%
|
-
|
|
Feb 17
2021
|
Charles Dadswell SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
386
+6.82%
|
-
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,194
-15.35%
|
$6,517,836
$494.24 P/Share
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,521
+22.2%
|
-
|
|
Feb 17
2021
|
Francis A De Souza President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,698
+4.21%
|
-
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,454
-20.64%
|
$718,276
$494.24 P/Share
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,173
+31.05%
|
-
|
|
Feb 17
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
350
+8.29%
|
-
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,762
-19.86%
|
$870,428
$494.24 P/Share
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+34.26%
|
-
|
|
Feb 17
2021
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
509
+10.7%
|
-
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
372
-14.44%
|
$183,768
$494.24 P/Share
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
935
+26.63%
|
-
|
|
Feb 17
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103
+5.91%
|
-
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
3,178
-24.84%
|
$1,569,932
$494.24 P/Share
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
6,306
+33.01%
|
-
|
|
Feb 17
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
BUY
Grant, award, or other acquisition
|
Direct |
694
+9.66%
|
-
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-23.2%
|
$1,071,980
$494.24 P/Share
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,379
+31.88%
|
-
|
|
Feb 17
2021
|
Sam Samad SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
482
+8.83%
|
-
|
|
Feb 17
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,178
-6.5%
|
$1,569,932
$494.24 P/Share
|
|
Feb 17
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,306
+11.42%
|
-
|
|
Feb 17
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
694
+1.6%
|
-
|
|
Feb 16
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Indirect |
500
-6.46%
|
$247,500
$495.09 P/Share
|
|
Feb 16
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.26%
|
$2,020,000
$505.26 P/Share
|
|
Feb 10
2021
|
Francis A De Souza President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,112
+9.43%
|
-
|
|
Feb 09
2021
|
Alexander Aravanis SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,208
+28.63%
|
-
|
|
Feb 09
2021
|
Charles Dadswell SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+22.0%
|
-
|
|
Feb 09
2021
|
Phillip G. Febbo SVP Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+28.15%
|
-
|
|
Feb 09
2021
|
Joydeep Goswami SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+25.13%
|
-
|
|
Feb 09
2021
|
Aimee L Hoyt SVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+26.96%
|
-
|
|
Feb 09
2021
|
Robert P Ragusa SVP, Global Quality & Ops |
BUY
Grant, award, or other acquisition
|
Direct |
1,656
+22.23%
|
-
|
|
Feb 09
2021
|
Kathryne Gambrell Reeves SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+34.96%
|
-
|
|
Feb 09
2021
|
Sam Samad SVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+23.49%
|
-
|
|
Feb 09
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,208
+5.0%
|
-
|
|
Feb 05
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
800
-1.97%
|
$344,800
$431.9 P/Share
|
|
Feb 02
2021
|
Karen K Mcginnis VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
72
-4.47%
|
$31,968
$444.84 P/Share
|
|
Feb 02
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.21%
|
$1,776,000
$444.84 P/Share
|
|
Feb 02
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
57
-2.36%
|
$25,308
$444.84 P/Share
|
|
Feb 01
2021
|
Francis A De Souza President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.46%
|
$1,317,000
$439.46 P/Share
|
|
Jan 20
2021
|
Susan H Tousi SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-5.82%
|
$1,000,000
$400.0 P/Share
|
|
Jan 19
2021
|
Jay T Flatley Director |
SELL
Open market or private sale
|
Direct |
4,000
-2.16%
|
$1,528,000
$382.48 P/Share
|
|
Jan 11
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Open market or private sale
|
Direct |
271
-10.3%
|
$102,709
$379.65 P/Share
|
|
Jan 08
2021
|
Aimee L Hoyt SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-4.15%
|
$43,206
$379.61 P/Share
|